Modern genetics offers the potential to revolutionize medicine. Genetic privacy also raises some of the toughest regulatory challenges of the 21st Century. This session looks at the practical challenges faced by life science businesses when developing necessary privacy programs. It focuses on law, regulations, and ethics as developing in Europe and the U.S.
Michael G. Hamilton, Chief Privacy Officer, Invitae
Maria Chiara Atzori, Head of Data Privacy, Novartis (Switzerland)